BPC-157, or Body Protective Compound-157, has demonstrated promising results in preclinical (animal-based) studies
doi: 10.1038/s41374-018-0021-z 176 Di MarzoVBifulcoMDe PetrocellisL
GHK-Cu's published research arc reaches back to its 1973 isolation from human plasma by Loren Pickart, with subsequent genomic profiling identifying expression changes across roughly 4,000 human genes
Neuroprotection Studied in preclinical and animal research on protecting neurons after ischemic and hypoxic injury
Retrieved June 10, 2025, from Mayo Clinic
Limit use to 46 weeks per cycle Take breaks between cycles to observe long-term effects Avoid stacking multiple peptides unless experienced or under medical supervision Talk to a Medical Professional While many users self-administer BPC-157, discussing peptide therapy with a knowledgeable healthcare provider particularly one familiar with sports medicine or functional healthcan help you: Avoid contraindications Customize dosage for your condition Monitor biomarkers or health responses BPC-157 is a powerful tool, but responsible use ensures the benefits outweigh any risks